Isomorphic Labs

AI drug discovery, machine learning, digital biology

discoverydiscoveringsmall molecule

isomorphiclabs.com·London, UK (in the King’s Cross neighbourhood), Lausanne, Switzerland (in Le Flon district) and Cambridge, MA (in Kendall Square)·Founded 2021·Series B·$5.4B total funding

01Overview 02People 03Projects 04Concepts 05Patents 06Public records 07Belief evolution

Plate C · C-JNNG

Belief evolution

AI-driven drug discovery mission2023-01-09

Isomorphic Labs states that it is a digital biology company aiming to redefine drug discovery using artificial intelligence. It says it believes there is a fundamental symmetry between biology and information science, and that by building the right team and platform it can discover and apply that symmetry.

Source

AI-first drug discovery2022-01-17

Isomorphic Labs states that it believes the drug discovery process should be reimagined from first principles and approached in an AI-first way, implying that artificial intelligence should be central to how new medicines are discovered and developed.

Source

company mission2021-11-04

Isomorphic Laboratories states that drug discovery should be reimagined from the ground up through an AI-first approach, with the goal of modeling and understanding some of the fundamental mechanisms of life. This reflects a belief that deeper computational understanding of biology can transform how new drugs are discovered.

Source

Loading

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence